Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome.

Rett syndrome is a neurological disorder caused by mutation of the X-linked MECP2 gene. Mice lacking functional Mecp2 display a spectrum of Rett syndrome-like signs, including disturbances in motor function and abnormal patterns of breathing, accompanied by structural defects in central motor areas and the brainstem. Although routinely classified as a neurodevelopmental disorder, many aspects of the mouse phenotype can be effectively reversed by activation of a quiescent Mecp2 gene in adults. This suggests that absence of Mecp2 during brain development does not irreversibly compromise brain function. It is conceivable, however, that deep-seated neurological defects persist in mice rescued by late activation of Mecp2. To test this possibility, we have quantitatively analysed structural and functional plasticity of the rescued adult male mouse brain. Activation of Mecp2 in ∼70% of neurons reversed many morphological defects in the motor cortex, including neuronal size and dendritic complexity. Restoration of Mecp2 expression was also accompanied by a significant improvement in respiratory and sensory-motor functions, including breathing pattern, grip strength, balance beam and rotarod performance. Our findings sustain the view that MeCP2 does not play a pivotal role in brain development, but may instead be required to maintain full neurological function once development is complete.

[1]  J. Raber,et al.  A role for glia in the progression of Rett’s syndrome , 2011, Nature.

[2]  Rodney C. Samaco,et al.  Adult Neural Function Requires MeCP2 , 2011, Science.

[3]  S. Cobb,et al.  Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal , 2011, Neuroscience.

[4]  R. Weksberg,et al.  Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation , 2011, Human molecular genetics.

[5]  J. Roux,et al.  Progressive motor and respiratory metabolism deficits in post-weaning Mecp2-null male mice , 2011, Behavioural Brain Research.

[6]  W. Kaufmann,et al.  Rett syndrome: Revised diagnostic criteria and nomenclature , 2010, Annals of neurology.

[7]  Fred H. Gage,et al.  A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells , 2010, Cell.

[8]  J. Paton,et al.  Correction of respiratory disorders in a mouse model of Rett syndrome , 2010, Proceedings of the National Academy of Sciences.

[9]  J. Eubanks,et al.  Diminished prevalence but preserved synaptic distribution of N-methyl-d-aspartate receptor subunits in the methyl CpG binding protein 2(MeCP2)-null mouse brain , 2010, Neuroscience.

[10]  D. Kunze,et al.  Exogenous Brain-Derived Neurotrophic Factor Rescues Synaptic Dysfunction in Mecp2-Null Mice , 2010, The Journal of Neuroscience.

[11]  James H. Eubanks,et al.  Alterations of cortical and hippocampal EEG activity in MeCP2-deficient mice , 2010, Neurobiology of Disease.

[12]  B. Morris,et al.  A Role for RhoB in Synaptic Plasticity and the Regulation of Neuronal Morphology , 2010, The Journal of Neuroscience.

[13]  L. Ricceri,et al.  Early postnatal behavioral changes in the Mecp2‐308 truncation mouse model of Rett syndrome , 2010, Genes, brain, and behavior.

[14]  Vinodh Narayanan,et al.  Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation , 2010, BMC Neuroscience.

[15]  S. Nelson,et al.  Pathophysiology of Locus Ceruleus Neurons in a Mouse Model of Rett Syndrome , 2009, The Journal of Neuroscience.

[16]  J. Ramirez,et al.  Respiratory Physiology & Neurobiology Breathing Disorders in Rett Syndrome: Progressive Neurochemical Dysfunction in the Respiratory Network after Birth , 2022 .

[17]  P. Dirks,et al.  MECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene Therapy , 2009, PloS one.

[18]  S. Kügler,et al.  Remodelling of the respiratory network in a mouse model of Rett syndrome depends on brain‐derived neurotrophic factor regulated slow calcium buffering , 2009, The Journal of physiology.

[19]  E. Masliah,et al.  Widespread changes in dendritic and axonal morphology in Mecp2‐mutant mouse models of rett syndrome: Evidence for disruption of neuronal networks , 2009, The Journal of comparative neurology.

[20]  S. Kudo,et al.  Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations , 2009, Neurobiology of Disease.

[21]  W. Mobley,et al.  Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation , 2009, Neurobiology of Disease.

[22]  Nathan R. Wilson,et al.  Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice , 2009, Proceedings of the National Academy of Sciences.

[23]  Michael P. Stryker,et al.  Reversing Neurodevelopmental Disorders in Adults , 2008, Neuron.

[24]  A. Hannan,et al.  Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome –Mecp2 gene dosage effects and BDNF expression , 2008, The European journal of neuroscience.

[25]  U. Francke,et al.  Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome , 2008, The Journal of comparative neurology.

[26]  Liang Zhang,et al.  The MeCP2‐null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability , 2008, Hippocampus.

[27]  E. Kavalali,et al.  Activity-Dependent Suppression of Miniature Neurotransmission through the Regulation of DNA Methylation , 2008, The Journal of Neuroscience.

[28]  M. Missler,et al.  Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. , 2008, Journal of neurophysiology.

[29]  Christian Rosenmund,et al.  MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number , 2007, Neuron.

[30]  M. Greenberg,et al.  Brain-Derived Neurotrophic Factor Expression and Respiratory Function Improve after Ampakine Treatment in a Mouse Model of Rett Syndrome , 2007, The Journal of Neuroscience.

[31]  N. Nag,et al.  Behavioral and anatomical abnormalities in Mecp2 mutant mice: A model for Rett syndrome , 2007, Neuroscience.

[32]  P. Maciel,et al.  Evidence for abnormal early development in a mouse model of Rett syndrome , 2007, Genes, brain, and behavior.

[33]  J. Roux,et al.  Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome , 2007, The European journal of neuroscience.

[34]  A. Bird,et al.  Reversal of Neurological Defects in a Mouse Model of Rett Syndrome , 2007, Science.

[35]  H. Zoghbi,et al.  MeCP2 dysfunction in Rett syndrome and related disorders. , 2006, Current opinion in genetics & development.

[36]  L. Ricceri,et al.  An altered neonatal behavioral phenotype in Mecp2 mutant mice , 2006, Neuroreport.

[37]  James H. Eubanks,et al.  Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome , 2006, Neurobiology of Disease.

[38]  H. Zoghbi,et al.  Learning and Memory and Synaptic Plasticity Are Impaired in a Mouse Model of Rett Syndrome , 2006, The Journal of Neuroscience.

[39]  Laurent Villard,et al.  Mecp2 Deficiency Disrupts Norepinephrine and Respiratory Systems in Mice , 2005, The Journal of Neuroscience.

[40]  D. Armstrong Can we relate MeCP2 deficiency to the structural and chemical abnormalities in the Rett brain? , 2005, Brain and Development.

[41]  Rudolf Jaenisch,et al.  Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Noriyuki Kishi,et al.  MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions , 2004, Molecular and Cellular Neuroscience.

[43]  R. Jaenisch,et al.  Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  V. Slonims,et al.  Regression in individuals with Rett syndrome , 2002, Brain and Development.

[45]  G. Jamal,et al.  Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder , 2001, Archives of disease in childhood.

[46]  R. Jaenisch,et al.  Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice , 2001, Nature Genetics.

[47]  A. Bird,et al.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome , 2001, Nature Genetics.

[48]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[49]  B. Antalffy,et al.  Decreased Dendritic Branching in Frontal, Motor and Limbic Cortex in Rett Syndrome Compared with Trisomy 21 , 1998, Journal of neuropathology and experimental neurology.

[50]  A. Dahlström,et al.  Morphological study of neocortical areas in Rett syndrome , 1996, Acta Neuropathologica.

[51]  B. Antalffy,et al.  Selective Dendritic Alterations in the Cortex of Rett Syndrome , 1995, Journal of neuropathology and experimental neurology.

[52]  B Hagberg,et al.  Rett syndrome: 3‐D confocal microscopy of cortical pyramidal dendrites and afferents , 1994, Neuroreport.

[53]  M. Segawa,et al.  Motor symptoms of the Rett syndrome: abnormal muscle tone, posture, locomotion and stereotyped movement. , 1992, Brain & development.

[54]  H. Nordgren,et al.  Rett syndrome: spinal cord neuropathology. , 1988, Pediatric neurology.